Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

How Bioventix Plc (LSE:BVXP) Maintains Sheep Monoclonal Antibody Supply Continuity for Automated Analysers in the FTSE AIM 50

The hallmark of Bioventix's corporate strategy is its capital-light, royalty-intensive financial model. Unlike traditional biopharmaceutical enterprises burdened by large clinical trial costs, Bioventix licenses antibodies to diagnostic partners in exchange for ongoingRoyaltystreams based on end-user test kit sales. Bioventix maintains an notable dividend track …

Ankur Sharma | 16 November 2026

FTSE 100 Large-Cap Value Stock GSK plc (LSE:GSK) Rallies as European Nod for Bexsero Booster Adds to Healthcare Bid

The recommendation is supported by a phase IIIb trial involving 312 participants, which met its primary endpoint and showed that immune memory from vaccination in infancy can be boosted up to 19 years later. GSK says a booster could help maintain protection into adolescence, …

Ankur Sharma | 16 November 2026

FTSE 100 Large-Cap Growth Stock Haleon PLC (LSE:HLN) Battles Back After Cold and Flu Slump Triggered Guidance Cut

This week, the shares remained under pressure. On 9 November, Haleon was the biggest faller in the FTSE 100, down 2.39% to 330.8p, as investors sold defensive names to chase cyclical stocks during a risk-on rally. By Friday, 13 November, the rotation back into …

Ankur Sharma | 16 November 2026

Eco Animal Health (LSE:EAH) Livestock Health Stock in Focus: FTSE AIM All-Share Small-Cap Value Veterinary Pharma Play

Eco Animal Health's financial half-year ends in September, and its interim results are typically published towards the end of the calendar year, so the company is moving into a period of heightened attention. As a small-cap value stock with established products and a cash-backed …

Ankur Sharma | 16 November 2026

HemoGenyx Pharmaceuticals (LSE:HEMO) Back in the Frame: LSE Main Market Small-Cap Growth Biotech Chasing a Leukaemia Breakthrough

That firmer tone at the top of the sector tends to spill over into smaller biotech companies, where investors look for early-stageAssetswith the potential to address significant unmet medical needs. For HemoGenyx, a small-cap growth stock, attention centres on its lead cell therapy for …

Ankur Sharma | 16 November 2026

ImmuPharma (LSE:IMM) Peptide Hopes Resurface: FTSE AIM All-Share Small-Cap Growth Biotech Targets Autoimmune Disease

Autoimmune disease remains one of the largest areas of unmet medical need, and new mechanisms that could modulate the immune system without broad suppression are of particular interest. For a small-cap growth stock such as ImmuPharma, attention tends to centre on the next steps …

Ankur Sharma | 16 November 2026

MedPal AI (LSE:MPAL) Digital Health Push Draws Traders: FTSE AIM All-Share Small-Cap Growth Stock Builds Health OS

The broader market showed a firm tone at the top end, with the FTSE 100 at a three-month high, while AIM was broadly flat. Digital health, particularly services linked to weight management medications, remains one of the fastest-growing segments of consumer healthcare, and MedPal …

Ankur Sharma | 16 November 2026

SkinBioTherapeutics (LSE:SBTX) Microbiome Momentum: FTSE AIM All-Share Small-Cap Growth Health Stock on Investor Radar

The microbiome, the community of bacteria living in and on the human body, has become one of the most discussed areas in consumer health and life sciences. For a small-cap growth stock such as SkinBioTherapeutics, attention tends to centre on commercial traction of its …

Ankur Sharma | 16 November 2026

ConvaTec Group plc (LSE:CTEC) in Focus Today: What Is Driving This mid cap growth Stock and What Comes Next?

Why is LSE:CTEC in focus today? The first reason is the interaction between recent trading momentum and expectations for the next corporate milestone. Investors tend to react most strongly when a company is approaching results, a trading update, a regulatory decision, a financing event, …

Ankur Sharma | 13 November 2026

Abingdon Health Plc (LSE:ABDX): FTSE AIM All-Share Small-Cap Growth Stock in Focus as Investors Track the Next Catalyst

• The stock is classified as a small-cap growth stock; this is a descriptive market classification, not anInvestmentrating.

Ankur Sharma | 13 November 2026
Support

Hi! How can we help you today?

Loading…